Search Results for: covid-19
Articles
N4 Pharma Provides Covid-19 Project & Operational Update April 3, 2020
N4 Pharma Plc, the specialist pharmaceutical company developing Nuvec, a novel delivery system for cancer treatments and vaccines, recently announced...Fast New Tests for Covid-19 on the Way April 3, 2020
At present, polymerise chain reaction (PCR) and antibody testing are the dominant ways that global healthcare systems are testing citizens...Saama Makes State-of-the-Art Clinical Analytics Platform Available to Integrate Data From All Organizations Investigating COVID-19 Treatments April 1, 2020
Saama Technologies, Inc. recently announced it will contribute its AI-powered Life Science Analytics Cloud (LSAC) technology platform to establish the EndPandemic National Data Consortium…..
Altimmune & the University of Alabama Collaborate on Development of Single-Dose, Intranasal COVID-19 Vaccine April 1, 2020
Altimmune, Inc. recently announced it is launching a collaboration with the University of Alabama at Birmingham (UAB) on the development of its single-dose…..
Covid-19 Outbreak in China Threatens Biopharma In-House Manufacturing March 26, 2020
With several mega cap biopharma companies having their vital manufacturing steps in Chinese facilities, the novel coronavirus (Covid-19) outbreak is putting the complicated global biopharma industry’s supply….
Pfizer & BioNTech to Co-develop Potential COVID-19 Vaccine March 18, 2020
Pfizer Inc. and BioNTech SE recently announced the companies have agreed to a letter of intent regarding the co-development and distribution (excluding China) of a….
Biomerica Begins Shipping Samples of 10-Minute Test for COVID-19 Virus Exposure March 18, 2020
Biomerica Inc. recently announced it has commenced shipping initial samples of its COVID-19 IgG/IgM Rapid Test (a finger prick blood test with results in…..
BeyondSpring Files for Patent Protection on BPI-002 for the Treatment of Viral Infections, Including COVID-19 March 12, 2020
BeyondSpring Inc. recently announced the submission of a provisional US patent application for its pipeline asset BPI-002, for methods of...Beroni Group Advances Research & Development of Medical Solution for Coronavirus (COVID-19) March 12, 2020
Beroni Group recently announced its development of a medical solution using nanobody technology for the novel coronavirus (COVID-19) in collaboration...Arcturus Therapeutics & Duke-NUS Medical School Partner to Develop a COVID-19 Vaccine March 5, 2020
Arcturus Therapeutics and Duke-NUS Medical School (Duke-NUS) recently announced their partnership to develop a Coronavirus….
Worldwide Research & Collaboration Needed to Combat Covid-19 March 5, 2020
In light of the coronavirus (COVID-19) outbreak, leading data and analytics company GlobalData has analyzed several of the largest COVID-19...Novavax Advances Development of Novel COVID-19 Vaccine February 26, 2020
Novavax, Inc. recently announced progress in its efforts to develop a novel vaccine to protect against coronavirus disease COVID-19….
Rentschler Biopharma Announces New State-of-the-Art Production Line in Massachusetts is Fully Operational July 11, 2024
Rentschler Biopharma SE recently announced the company’s new state-of-the-art production line, formerly known as the Rentschler Biopharma Manufacturing Center (RBMC),...CureVac Initiates Strategic Restructuring to Align Resources With Focus on High-Value mRNA Pipeline Opportunities July 3, 2024
CureVac N.V. recently announced a significant strategic restructuring to focus its resources on high-value mRNA projects in oncology and other...API & the University of Alberta Break Ground on Canada’s Largest Manufacturing Facility for Critical Medicines June 20, 2024
Construction is set to begin on a crucial pharmaceutical manufacturing facility in the Edmonton Research Park that will provide Canadians...Truveta Announces Support for Regulatory Submissions to the FDA & Global Regulatory Authorities June 18, 2024
Truveta recently announced regulatory and audit capabilities to support its customers for real-world evidence (RWE) submissions to the US FDA...Atriva Therapeutics Secures US Patent for First-in-Class Broad Spectrum Therapy for Severe RNA Virus Infections Including Bird Flu June 6, 2024
Atriva Therapeutics recently announced it has been granted a US patent for its MEK inhibitor zapnometinib (ATR-002). The patent includes...First Participants Vaccinated in IMUNON’s Phase 1 Clinical Trial June 5, 2024
IMUNON, Inc. recently announced the first participants have been treated in the IMNN-101 Phase 1 clinical trial. This proof-of-concept study...ExeVir Bio Announces Exceptional Virus Neutralization Potency of its Variant-Proof Antibody Against the SARS-CoV-2 Variant JN.1 June 4, 2024
ExeVir Bio recently announced new data demonstrating its antibodies are exceptionally potent in neutralizing the SARS-CoV-2 variant JN.1, the parental...CONTAINER PLATFORMS - Ready-to-Use Containers: Real Benefits, Important Challenges & Evolving Value June 3, 2024
Gregor Deutschle and Gabriele Maier examine key benefits, dynamics driving the adoption of RTU container platforms, and several important areas of continuing evolution in the RTU market.